RE:RE:if the stock couldn't rally todaybut every healthcare stock did though haha
Only two i know that have not done well were the original healthcare cos (CPH and RX). They had their year back in 2013 early 2014.
Now, there's so many others that are taking attention away from these names that have high single drug risk and are not attractive anymore relative to the new emerging ones.
Look at CXR, CRH, NHC, TH, RVX, PHM, etc. These are all up huge. Their relative outperformance against CPH is a minimum of 100% ytd. as much as +300-400% at the high end.ha
CPH is a loser stock. Just look at it. Don't say post facts. Because all you have to do is look at the share price. Just look at it for a change Lieseeker.
Even at 11 bucks, this stock trades at ~25x eps. TOO EXPENSIVE FOR A HIGH RISK SINGLE DRUG WONDER WHO'S MARKET SHARE IS PEAKING WITH NO VIABLE AND IMMEDIATE GROWTH PLANS.